News - Purdue Pharma


Current filters:

Purdue Pharma

Popular Filters

Purdue Pharma names Mark Timney president and CEO


Privately-held US drugmaker Purdue Pharma has appointed Mark Timney as president and chief executive.…

BoardroomManagementPharmaceuticalPurdue Pharma

Prescription painkiller overdoses has risen 400% in women, says the US CDC


Women in the USA are dying from prescription painkiller overdoses at rates never seen before, according…

Endo Health SolutionsGenericsHealthcareMethadoneOpanaOxyContinPurdue PharmaResearchVicodinWomen's Health

Grunenthal licensing deal with Purdue Pharma; management reorganization


Family-owned German drugmaker Grunenthal has entered into a licensing agreement with privately-held US…

LicensingManagementMorphine SulfateNeurologicalPharmaceuticalPurdue Pharma

Actavis in OxyContin patent settlement; Valeant takeover bid "on hold"?


US generic major Actavis (NYSE: ACT) has entered into an agreement with privately-held Purdue Pharma…

ActavisGenericsMergers & AcquisitionsNeurologicalNorth AmericaOxyContinPatentsPurdue PharmaValeant Pharmaceuticals

Infinity regains global rights to PI3K, FAAH; equity investment by Purdue


USA-based Infinity Pharmaceuticals (Nasdaq: INFI) says it has restructured its strategic alliance with…

FinancialInfinity PharmaceuticalsLicensingMundipharmaPharmaceuticalPurdue PharmaResearch

FDA approves Transcept Pharma’s Intermezzo mid-night insomnia treatment


US drugmaker Transcept Pharmaceuticals (Nasdaq: TSPT) saw its shares jump 11% to $7.34 yesterday, after…

IntermezzoNeurologicalNorth AmericaPharmaceuticalPurdue PharmaRegulationTranscept Pharmazolpidem

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top